Abbott Laboratories (NYSE:ABT) 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 12:00 PM ET Company Participants Robert Ford - Chairman and Chief Executive Officer Conference Call Participants Robbie Marcus - J.P. Morgan Robbie Marcus Good morning, everyone. Welcome. I'm Robbie Marcus, medtech analyst at J.P. Morgan. Really happy to introduce our next session with Abbott Labs and the CEO Robert Ford. Robert, thanks for joining. Robert Ford Thanks for having us. Question-and-Answer Session Q - ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-2189 ABBOTT LABORATORIES An Illinois Corporation I.R.S. Employer Identification No. 36-0698440 100 Abbott Park ...

Abbott Laboratories (NYSE:ABT) Q3 2022 Earnings Conference Call October 19, 2022 9:00 AM ET Company Participants Scott Leinenweber - Vice President, Investor Relations, Licensing and Acquisition Robert Ford - Chairman and CEO Bob Funck - Executive Vice President, Finance and CFO Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Joanne Wuensch - Citibank Josh Jennings - Cowen Vijay Kumar - Evercore ISI Travis Steed - Bank of America Operator Good morning and thank you for st ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-2189 ABBOTT LABORATORIES An Illinois Corporation I.R.S. Employer Identification No. 36-0698440 100 Abbott Park Road ...

Abbott Laboratories (NYSE:ABT) Q2 2022 Earnings Conference Call July 20, 2022 9:00 AM ET Company Participants Scott Leinenweber - Vice President, Investor Relations, Licensing & Acquisition Robert Ford - Chairman & Chief Executive Officer Bob Funck - Executive Vice President, Finance & Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Joshua Jennings - Cowen Larry Biegelsen - Wells Fargo Joanne Wuensch - Citi Vijay Kumar - Evercore ISI Travis Steed - Bank of America Jayson Bedfor ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-2189 ABBOTT LABORATORIES An Illinois Corporation I.R.S. Employer Identification No. 36-0698440 100 Abbott Park Road ...

Abbott Laboratories (NYSE:ABT) Q1 2022 Earnings Conference Call April 20, 2022 9:00 AM ET Company Participants Scott Leinenweber - Vice President, Investor Relations, Licensing and Acquisition Robert Ford - Chairman and Chief Executive Officer Bob Funck - Executive Vice President Finance and Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Vijay Kumar - Evercore ISI Josh Jennings - Cowen and Company Larry Biegelsen - Wells Fargo Joanne Wuensch - Citigroup Travis Steed - Bank ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission file number 1-2189 Abbott Laboratories An Illinois Corporation 36-0698440 100 Abbott Park Road Abbott Park, Illinois 60064-6400 (I.R.S. employer identification number) (224) 667-6100 ...